Results 111 to 120 of about 1,453,502 (192)

Natural biomaterials in the management of the aortic valve pathology. Biomedical and clinical aspects: A review

Biomolecules & Biomedicine
Heart valve diseases are a prevalent cardiovascular pathology worldwide, affecting nearly 2.5% of the population. Degenerative aortic stenosis is the most common form of heart valve disease.
Igor Mokryk, Illia Nechai, Christoph Schmitz, Ihor Stetsyuk, Oleksandr Talalaiev, Borys Todurov   +5 more
doaj   +1 more source

A three-dimensional computation of fluid-structure interaction in bioprosthetic heart valves using immersed membrane method

, 2006
This work aims to apply Computational Fluid Dynamics (CFD) and Computational Structural Dynamics (CSD) to simulate the motions of bioprosthetic heart valves and the flow field around them.
Xia, Guohua
core   +1 more source

Pregnancy-Induced Remodeling of Heart Valves

, 2014
Although many cardiovascular tissues have been shown to remodel when exposed to chronic changes in hemodynamic stresses, little is known about the capacity of heart valves to adapt in a non-disease state such as pregnancy.
Pierlot, H Caitlin M
core  

Studies on glycosphingolipids as immune targets in bioprosthetic heart valves [PDF]

, 2016
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Drug Control Candidate: Petr Jansa Supervisor: prof. PharmDr. Martin Doležal, Ph.D. Supervisor - specialist: prof.
Jansa, Petr
core  

Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves. [PDF]

JACC Basic Transl Sci, 2020
Frasca A, Xue Y, Kossar AP, Keeney S, Rock C, Zakharchenko A, Streeter M, Gorman RC, Grau JB, George I, Bavaria JE, Krieger A, Spiegel DA, Levy RJ, Ferrari G.   +14 more
europepmc   +1 more source

Off-label Use of Direct Oral Anticoagulants in Patients Receiving Surgical Mechanical and Bioprosthetic Heart Valves.

JAMA Netw Open, 2021
Kalra A, Raza S, Jafry BH, King HE, Lahorra JA, Svensson LG, Kapadia SR.   +6 more
europepmc   +1 more source

Nanoparticle Biofunctionalization of Bioprosthetic Heart Valves to Modulate Mechanisms of Structural Valve Deterioration. [PDF]

JACC Basic Transl Sci
Grant AJ, Chan AHP, Xu XS, Lau K, Mitchell TC, Hung J, Michael PL, Santos M, Lee A, Giaretta J, Goh T, Tsao CH, Waterhouse A, Naficy S, Rnjak-Kovacina J, Ng MKC, Wise SG, Tan RP.   +17 more
europepmc   +1 more source

Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease. [PDF]

Cardiooncology
Scalia IG, Abdelfattah FE, Farina JM, Ibrahim OH, Awad K, Crestanello JA, Schaff HV, Halfdanarson TR, Ray JC, Pellikka PA, Connolly HM, Arsanjani R, Ayoub C.   +12 more
europepmc   +1 more source

Enzyme-responsive hydrogel coating for <i>in situ</i> re-endothelialization of bioprosthetic heart valves. [PDF]

Theranostics
Liang X, Tong Q, Bei Z, Luo T, Ye L, Pan M, Yang Y, Chu B, Qian Y, Qian Z.   +9 more
europepmc   +1 more source

Quantification of Alpha-Gal Expression in Commercial BioProsthetic Heart Valves and Its Potential Mitigation. [PDF]

Struct Heart
Colli A, Zilla P, Calafiore AM, Padalino M, Naso F, George I.   +5 more
europepmc   +1 more source